Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...

Marty Makary, a Johns Hopkins surgeon and outspoken critic of parts of the U.S. medical system, is Trump’s pick for FDA ...

Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...

Front-month gold futures fell Monday in the largest one-day decline by dollar amount since November 2020, as news of a ...

Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug ...

GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial ...

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...

Traders and investors watched Wall Street's major averages finish Monday on a positive note where the blue-chip Dow outshined ...

After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.

Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

President-elect Donald Trump’s proposed lineup to lead the government’s health agencies look like bad news for vaccine ...